Success Factors and Failure Points in Metabolic Product Launches
Vadivel Parthsarathy PhD February 2013 How are drugs discovered and developed?
Jefferies 2010 Healthcare Conf
FDA and Patient Interactions On Benefit-Risk Determinations
The Importance of Biomarkers in Hematology/Oncology Drug Development - Steven Fruchtman
Ucm358301
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinical Manufacturing Hurdles Early A presentation by Chief Operating Officer, Dr Stephen Ward Nov 2013
Business-led Translation A presentation by CEO, Keith Thompson, about growing a UK cell therapy industry. Oct 2013
Working with the FDA
FDA Advisory Panel Miltenyi Biotec CliniMACS ® CD34 Reagent System September 23, 2011 With Sincere Thanks and Appreciation To:
Overview of Pharmaceutical Industry Drug nomenclature and classification Pharmacokinetics Pharmacodynamics Psych 181: Lecture 3 Professor Anagnostaras.
Managing Tough Decisions With Decision Analysis INFORMS Southern California Chapter Meeting California State University, Northridge Phil Beccue.
